{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:15:54Z","timestamp":1790885754199,"version":"4.1.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1,1]]},"DOI":"10.1097\/qai.0b013e31823d3aba","type":"journal-article","created":{"date-parts":[[2011,10,25]],"date-time":"2011-10-25T04:15:02Z","timestamp":1319516102000},"page":"25-30","source":"Crossref","is-referenced-by-count":42,"title":["Loss to Follow-Up and Mortality Among HIV-Infected People Co-Infected With TB at ART Initiation in Durban, South Africa"],"prefix":"10.1097","volume":"59","author":[{"given":"Ingrid V.","family":"Bassett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senica","family":"Chetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilda","family":"Mazibuko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Giddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rochelle P.","family":"Walensky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth A.","family":"Freedberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Losina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-4-20210131","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.aids.0000238406.93249.cd","article-title":"Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control.","volume":"20","author":"Lawn","year":"2006","journal-title":"AIDS"},{"key":"R3-4-20210131","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1097\/01.aids.0000194802.89540.e1","article-title":"Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design.","volume":"19","author":"Lawn","year":"2005","journal-title":"AIDS"},{"key":"R4-4-20210131","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/QAD.0b013e328013f632","article-title":"Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda.","volume":"21","author":"Moore","year":"2007","journal-title":"AIDS"},{"key":"R6-4-20210131","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1086\/656282","article-title":"Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa.","volume":"51","author":"Bassett","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R7-4-20210131","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/QAD.0b013e3283390dd1","article-title":"Tuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy.","volume":"24","author":"Lawn","year":"2010","journal-title":"AIDS"},{"key":"R8-4-20210131","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.296.7.782","article-title":"Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes.","volume":"296","author":"Stringer","year":"2006","journal-title":"JAMA"},{"key":"R9-4-20210131","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/QAD.0b013e328325d115","article-title":"Effect of pulmonary tuberculosis on mortality in patients receiving HAART.","volume":"23","author":"Westreich","year":"2009","journal-title":"AIDS"},{"key":"R10-4-20210131","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1097\/QAD.0b013e32832e05c8","article-title":"Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease.","volume":"23","author":"Lawn","year":"2009","journal-title":"AIDS"},{"key":"R11-4-20210131","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/QAI.0b013e318196761c","article-title":"Intensified tuberculosis case finding among HIV-Infected persons from a voluntary counseling and testing center in Addis Ababa, Ethiopia.","volume":"50","author":"Shah","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R12-4-20210131","first-page":"204","article-title":"Predictors of mortality in patients initiating antiretroviral therapy in Durban, South Africa.","volume":"98","author":"Ojikutu","year":"2008","journal-title":"S Afr Med J"},{"key":"R13-4-20210131","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/QAI.0b013e3181a44ef2","article-title":"Loss to care and death before antiretroviral therapy in Durban, South Africa.","volume":"51","author":"Bassett","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R16-4-20210131","doi-asserted-by":"crossref","first-page":"e10527","DOI":"10.1371\/journal.pone.0010527","article-title":"Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa.","volume":"5","author":"Hermans","year":"2010","journal-title":"PLoS ONE"},{"key":"R17-4-20210131","doi-asserted-by":"crossref","first-page":"e14149","DOI":"10.1371\/journal.pone.0014149","article-title":"Adjusting Mortality for loss to follow-up: analysis of 5ive ART programmes in Sub-Saharan Africa.","volume":"5","author":"Brinkhof","year":"2010","journal-title":"PLoS ONE"},{"key":"R18-4-20210131","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1001\/jama.300.5.506","article-title":"Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa.","volume":"300","author":"Geng","year":"2008","journal-title":"JAMA"},{"key":"R19-4-20210131","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/QAD.0b013e328329148e","article-title":"Clinical experience with the combined use of lopinavirritonavir and rifampicin.","volume":"23","author":"LHomme","year":"2009","journal-title":"AIDS"},{"issue":"suppl 1","key":"R20-4-20210131","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1086\/518655","article-title":"Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome.","volume":"196","author":"McIlleron","year":"2007","journal-title":"J Infect Dis"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00126334-201201010-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:22:45Z","timestamp":1786047765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-201201010-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e31823d3aba","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1,1]]}}}